To investigate the associations of monocyte activation with SLE disease progression, we assessed the correlations between monocyte activation markers and clinical tests of lupus disease activity, including serum creatinine, serum C3 and C4, the SLE disease Activity Index (SLEDAI), and the disease damage index (SLICC DI). The gene discussed is C4A; the disease is systemic lupus erythematosus.